Liquisolid technique is based upon the admixture of drug loaded solutions with appropriate carrier and coating materials. The use of non-volatile solvent causes improved wettability and ensures molecular dispersion of drug in the formulation and leads to enhance solubility. By using hydrophobic carriers (non-volatile solvents) one can modify release (sustained release) of drugs by this technique. Liquisolid compacts demonstrated a considerably higher drug dissolution rates than those of conventionally made capsules and directly compressed tablets. This was due to the increased wetting properties and surface of drug available for dissolution. Liquisolid technique is a new and promising method that can enhance the dissolution rate of drugs. This review paper highlights the advantages, disadvantages, mechanism of enhanced drug release, classification, evaluation and application of liquisolid technique to enhance the solubility and dissolution of water insoluble drugs. Liquisolid system is characterized by flow behavior, wettability, powder bed hydrophilicity, saturation solubility, drug content, differential scanning calorimetry, Fourier transform infra red spectroscopy, powder X-ray diffraction, scanning electron microscopy, in-vitro release and in-vivo evaluation. By using this technique, solubility and dissolution rate can be improved, sustained drug delivery systems be developed for the water soluble drugs.
Cite this article:
Asija Rajesh, Patel Pinkesh, Asija Sangeeta. The Liquisolid Technique for Enhancement of Drug Dissolution. Research J. Pharm. and Tech. 5(10): October 2012; Page 1270-1274.
1. Patravale VB, Date AA and Kulkarni RM.
Nanosuspensions: a Promising Drug Delivery Strategy. J Pharm Pharmacol. 56; 2004: 827-840.
N, Katare OP and Singh B. Studies on dissolution enhancement and mathematical
modeling of drug release of a poorly water-soluble drug using water-soluble carriers.
Eur J Pharm Biopharm 65; 2007:
GL et al. A theoretical Basis for Biopharmaceutic Drug Classification: The
Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability. Pharm Res. 12; 1995:413-420.
E. Liversidge nanocrystals: resolving pharmaceutical formulation issues
associated with poorly soluble compounds in: JJ matty (Ed), Particles. Orlando:
Marcel Dekker publisher. 2002.
CC and Jarowski CI. Dissolution Rates of Corticoid Solutions Dispersed on
Silicas. J Pharm Sci. 73; 1984: 401-403.
AS and Pavani E. The Liquisolid Technique: Based Drug Delivery System. International Journal of Pharmaceutical
Sciences and Drug Research. 4(2); 2012: 88-96.
Sahil MG et al. Liquisolid compact: a new technique
for enhancement of drug dissolution. IJRPC. 1(3); 2011: 705-713.
Santhosh KK et al. Solubility enhancement of a drug
by liquisolid technique. International Journal of Pharma and Bio Sciences.
1(3); 2010: 1-5.
9. Javadzadeh Y et al. Enhancement of dissolution rate of
Piroxicam using Liquisolid Compacts.
Farmaco. 60; 2005: 361-365.
10. Spireas S and Sadu S. Enhancement of Prednisolone
dissolution properties using Liquisolid Compacts. Int J Pharm. 166; 1998: 177-188.
11. Spireas S, Sadu S and Grover R. In vitro release evaluation
of hydrocortisone Liquisolid tablets. J
Pham Sci. 87; 1998: 867-872.
12. Nokhodchi A et al. The effect of type and
concentration of vehicles on the dissolution rate of a poorly Soluble drug
(Indomethacin) from Liquisolid Compacts. J
Pharm Sci. 8; 2005: 18-25.
13. Yadav VB and Yadav AV. Improvement of solubility and
dissolution of indomethacin by Liquisolid and Compaction granulation
techniques. J Pharm Sci and Res. 1;
14. Yadav VB and Yadav AV. Liquisolid granulation
techniques for tablets manufacturing: An overview. J Pharmacy Res. 2; 2009: 610-674.
15. Yadav VB and Yadav AV. Enhancement of Solubility and
dissolution rate of BCS class 2 pharmaceuticals by non aqueous granulation
technique. Int J Pharm Res Dev. 1;
16. Yadav VB et al. Aceclofenac size Enlargement by non
aqueous granulation with improved solubility and dissolution. Arch Pharm Sci Res. 1; 2009: 115-122.
17. Khaled KA, Asiri YA, El-Sayed YM. In Vivo evaluation
of Hydrochlorothiazide Liquisolid Tablet in beagles dogs. Int J Pharm. 222; 2001: 1-6.
18. Bhise SB et al. Aceclofenac size
enlargement by non aqueous granulation with improved solubility and
dissolution. Arch Pharm Sci & Res.
1; 2009: 115-122.
19. Jarowski CI, Rohera BD and Spireas S.
Powdered solution technology: principles and mechanism. Pharm Res. 9; 1992: 1351-1358.
20. Nokhodchi A, Hentzschel CM and Leopord CS.
Drug release from liquisolid system: speed it up, slow it down. Expert Opin Drug Del. 8; 2011: 191-205.
21. Barzegar JM et al. Enhancement of
dissolution rate of piroxicam using liquisolid compacts. II Farmaco. 60; 2005: 361-365.
22. Naseem A et al. Effects of plasma
irradiation on the wettability and dissolution of compacts of griseofulvin. Int J Pharm. 269; 2004: 443-450.
23. Sadu S, Spireas S and Grover R. In vitro
release evaluation of hydrocortisone liquisolid tablets. J Pharm Sci. 87; 1998: 867-872.
24. Rakshit P, Ridhish P and Moinuddin S.
Formulation and evaluation of liquisolid compacts of piroxicam. Ind drugs. 44; 2007: 967-972.
25. Spiro S and Srinivas S. Enhancement of
Prednisolone dissolution properties using liquisolid compacts. Int J Pharm. 166; 1998:177-188.
Yadav VB and Yadav AV. Liquisolid granulation
technique for tablet manufacturing: an overview. Journal of Pharmacy Research. 2(4); 2009: 670-674.
KA. Formulation and evaluation of hydrochlorothiazide liquisolid tablets. Saudi Pharm J. 6; 1988: 39-46.
SS, Jarowski CI and Rohera BD. Powdered solution technology: principles and
mechanism. Pharm Res. 9; 1992:
29. Fukuda M, Peppas NA and McGinity JW.
Properties of sustained release hot melt extruded tablets containing chitosan
and xanthan gum. Int J Pharm. 310;